Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 3;15(1):1.
doi: 10.1186/s13023-019-1279-y.

The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers

Affiliations

The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers

Anna L Bruckner et al. Orphanet J Rare Dis. .

Abstract

Background: Little information is available regarding the burden of living with and managing epidermolysis bullosa, including the distinct challenges faced by patients with different disease types/subtypes.

Methods: A 90-question/item survey was developed to collect demographics, diagnostic data, management practices, and burden of illness information for patients with epidermolysis bullosa living in the United States. Recruitment was conducted via email and social media in partnership with epidermolysis bullosa patient advocacy organizations in the United States, and the survey was conducted via telephone interview by a third-party health research firm. Respondents aged ≥ 18 years with a confirmed diagnosis of epidermolysis bullosa or caring for a patient with a confirmed diagnosis of epidermolysis bullosa were eligible to participate in the survey.

Results: In total, 156 responses were received from patients (n = 63) and caregivers (n = 93) representing the epidermolysis bullosa types of simplex, junctional, and dystrophic (subtypes: dominant and recessive). A large proportion of patients (21%) and caregivers (32%) reported that the condition was severe or very severe, and 19% of patients and 26% of caregivers reported a visit to an emergency department in the 12 months prior to the survey. Among the types/subtypes represented, recessive dystrophic epidermolysis bullosa results in the greatest wound burden, with approximately 60% of patients and caregivers reporting wounds covering > 30% of total body area. Wound care is time consuming and commonly requires significant caregiver assistance. Therapeutic options are urgently needed and reducing the number and severity of wounds was generally ranked as the most important treatment factor.

Conclusions: Survey responses demonstrate that epidermolysis bullosa places a considerable burden on patients, their caregivers, and their families. The limitations caused by epidermolysis bullosa mean that both patients and caregivers must make difficult choices and compromises regarding education, career, and home life. Finally, survey results indicate that epidermolysis bullosa negatively impacts quality of life and causes financial burden to patients and their families.

Keywords: Caregivers; Disease burden; Epidermolysis bullosa; Financial burden; Management; Patients; Quality of life; Survey; Wound care.

PubMed Disclaimer

Conflict of interest statement

ALB has served as a consultant and an investigator for Amicus Therapeutics/Scioderm and Castle Creek, and as an investigator for Amryt, Fibrocell, ProQR, and Phoenix Tissue Repair.

JW, NP, AR, HL, ML, and JGa, are employees of and hold stock in Amicus Therapeutics.

JGe is the co-founder and vice chair on the board of Profession Patient Advocates in Life Sciences; a member of the board of trustees for the Healthcare Institute of New Jersey; a member of the board of directors for the Together Strong Foundation for NPC, and an employee of, and a stock holder and patent holder in, Amicus Therapeutics.

BK is an employee of Debra of America.

MH is an employee of EB Research Partnership.

DFM has served as an investigator for Amicus Therapeutics, Amryt, Castle Creek, and Shire, and has served as an advisor for Amicus and Shire.

Figures

Fig. 1
Fig. 1
a Patient- and b caregiver-reported severity of epidermolysis bullosaa. aTwo patients (1 self-reported and 1 caregiver-reported) had another type or unknown type of epidermolysis bullosa
Fig. 2
Fig. 2
Patient- and caregiver-reported complications experienced due to epidermolysis bullosa. Respondents ticked all applicable answers. aOthers: anxiety (n = 1); blisters (n = 1); low iron (n = 1); severe internal pains, cause unknown (n = 1). GERD gastroesophageal reflux disease
Fig. 3
Fig. 3
Intensity of wound pain and itch (scored from 1 to 10) in the past 2 weeks as reported by a patients and caregivers, b as reported by patients by type,a and c as reported by caregivers by typea. aOne patient had another type or unknown type of epidermolysis bullosa and was excluded from analysis
Fig. 4
Fig. 4
Life decisions resulting from epidermolysis bullosa from the a patient’s perspective (n = 63) and b caregiver’s perspective (n = 93). Respondents ticked all applicable answers. Eight of 93 caregivers did not select any of the listed life decisions. Interviewers may or may not have provided the definition of preimplantation genetic testing

References

    1. El Hachem M, Zambruno G, Bourdon-Lanoy E, Ciasulli A, Buisson C, Hadj-Rabia S, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis. 2014;9:76. doi: 10.1186/1750-1172-9-76. - DOI - PMC - PubMed
    1. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5:12. doi: 10.1186/1750-1172-5-12. - DOI - PMC - PubMed
    1. Ma JE, Hand JL. What's new with common genetic skin disorders? Minerva Pediatr. 2017;69:288–297. - PubMed
    1. Tabor A, Pergolizzi JV, Jr, Marti G, Harmon J, Cohen B, Lequang JA. Raising awareness among healthcare providers about epidermolysis bullosa and advancing toward a cure. J Clin Aesthet Dermatol. 2017;10:36–48. - PMC - PubMed
    1. Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103–1126. doi: 10.1016/j.jaad.2014.01.903. - DOI - PubMed

Publication types

LinkOut - more resources